NasdaqGS - Nasdaq Real Time Price USD

Contineum Therapeutics, Inc. (CTNM)

Compare
5.85
-0.28
(-4.39%)
As of 9:36:39 AM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
--
--
50,000
--
--
Operating Expense
50,894
50,894
33,923
22,720
28,647
Operating Income
-50,894
-50,894
16,077
-22,720
-28,647
Net Non Operating Interest Income Expense
8,905
8,905
4,398
373
-255
Other Income Expense
-269
-269
2,695
-1,906
-99
Pretax Income
-42,258
-42,258
23,170
-24,253
-29,001
Tax Provision
--
--
450
--
--
Net Income Common Stockholders
-42,258
-42,258
22,720
-24,253
-29,001
Diluted NI Available to Com Stockholders
-42,258
-42,258
22,720
-24,253
-29,001
Basic EPS
-0.36
-2.18
0.84
-1.45
-1.74
Diluted EPS
-0.36
-2.18
0.84
-1.45
-1.74
Basic Average Shares
25,736.08
19,352.86
27,055.79
16,674.15
16,674.15
Diluted Average Shares
25,736.08
19,352.86
27,055.79
17,760.69
17,760.69
Total Operating Income as Reported
50,894
50,894
-16,077
-22,720
-28,647
Total Expenses
50,894
50,894
33,923
22,720
28,647
Net Income from Continuing & Discontinued Operation
-42,258
-42,258
22,720
-24,253
-29,001
Normalized Income
-42,152
-42,152
19,903.78
-22,439
-28,993
Interest Income
8,905
8,905
4,606
761
77
Interest Expense
--
--
208
388
332
Net Interest Income
8,905
8,905
4,398
373
-255
EBIT
-42,258
-42,258
23,378
-23,865
-28,669
EBITDA
-42,000
-42,000
23,573
-23,536
-28,344
Reconciled Depreciation
258
258
195
329
325
Net Income from Continuing Operation Net Minority Interest
-42,258
-42,258
22,720
-24,253
-29,001
Total Unusual Items Excluding Goodwill
-106
-106
2,872
-1,814
-8
Total Unusual Items
-106
-106
2,872
-1,814
-8
Normalized EBITDA
-41,894
-41,894
20,701
-21,722
-28,336
Tax Rate for Calcs
--
--
0
--
--
Tax Effect of Unusual Items
--
--
55.78
--
--
12/31/2021 - 4/5/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BOLD Boundless Bio, Inc.
1.3550
-1.78%
 
ARTV Artiva Biotherapeutics, Inc.
2.5000
-1.57%
 
RAPP Rapport Therapeutics, Inc.
7.94
-6.81%
 
MBX MBX Biosciences, Inc.
6.42
+0.78%
 
CAMP CAMP4 THERAPEUTICS CORPORATION
3.1200
+0.97%
 
AARD Aardvark Therapeutics, Inc.
8.00
-7.94%
 
MOLN Molecular Partners AG
3.7201
+0.00%
 
MAZE Maze Therapeutics, Inc.
8.50
-8.87%
 
TSBX Turnstone Biologics Corp.
0.3770
0.00%
 
SYRE Spyre Therapeutics, Inc.
13.63
-2.57%